spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  HbA1c 

 HSMN NewsFeed - 10 Jun 2024
Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems
Devices Endocrinology Monitoring FDA
 HSMN NewsFeed - 22 Sep 2022
Rivus Pharmaceuticals Closes $132 Million Series B Financing to Advance HU6 for the Treatment of Obesity and Cardio-Metabolic Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Mar 2022
Abbott's FreeStyle(R) Libre is First and Only CGM System to Gain Expanded Reimbursement in Japan to Include All People with Diabetes Who Use Insulin
Devices Monitoring Reimbursement
 HSMN NewsFeed - 20 Oct 2021
vTv Therapeutics Announces Deepa Prasad as New President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Dec 2020
Abbott's FreeStyle Libre 2 Now Approved for Adults and Children with Diabetes in Canada, Featuring Unsurpassed 14-Day Accuracy and Optional Alarms
Devices Monitoring Endocrinology Regulatory
 HSMN NewsFeed - 31 Aug 2020
Mylan and Biocon Biologics Announce Launch of Semglee(TM) (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 15 Jun 2020
Abbott's FreeStyle(R) Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes, Achieving Highest Level of Accuracy and Performance Standards
Devices Monitoring Endocrinology FDA
 HSMN NewsFeed - 26 Feb 2020
Oramed Reports Positive Results in the Final Cohort of Its Phase 2b Oral Insulin Trial
Biopharmaceuticals Drug Delivery Endocrinology
 HSMN NewsFeed - 20 Sep 2019
CHMP Issues Positive Opinion to Expand Trulicity(R) (dulaglutide) Label to Include Results from REWIND Cardiovascular Outcomes Trial
Biopharmaceuticals Endocrinology Cardiology Regulatory
 HSMN NewsFeed - 22 Aug 2019
Drawbridge Health Receives FDA 510(k) Clearance for OneDraw(TM) A1C Test System
Devices Diagnostics FDA
 HSMN NewsFeed - 30 May 2019
Whole Biome Secures $35 Million in Series B Financing for Expansion of its Microbiome Discovery Platform and Commercialization of its First Product
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 20 Feb 2019
HemoCue Announces FDA 510(k) Clearance and U.S. Launch of Its Latest Point-of-Care Hemoglobin Test, the HemoCue(R) Hb 801 System
Diagnostics FDA Product Launch
 HSMN NewsFeed - 20 Feb 2019
Hygieia Receives 510(k) Clearance from FDA for Phone App That Enhances Company's d-Nav Insulin Guidance Service
Devices Endocrinology FDA
 HSMN NewsFeed - 31 May 2018
Abbott Introduces the Afinion(TM) 2 Analyzer Rapid Test System for Diabetes Management
Diagnostics Endocrinology Product Launch
 HSMN NewsFeed - 10 Jan 2018
BYDUREON(R) BCise(TM) Injectable Medicine Now Available In The US For Patients With Type-2 Diabetes
Biopharmaceuticals Endocrinology Product Launch
 HSMN NewsFeed - 28 Dec 2017
Integrity Applications Signs Distribution Agreement for Its GlucoTrack(R) Non-Invasive Glucose Monitoring Device in the Netherlands
Devices Endocrinology Distribution
 HSMN NewsFeed - 18 Sep 2017
ARKRAY launches ADAMS(TM) A1c HA-8180V System for hemoglobin A1c testing
Diagnostics FDA Product Launch
 HSMN NewsFeed - 21 Jun 2017
EnteroMedics Announces vBloc Therapy to be Presented by Keynote Speaker at Major International Obesity Conference
Devices
 HSMN NewsFeed - 31 May 2017
EnteroMedics Announces First vBloc(R) Neurometabolic Therapy Implant at AMITA Health Adventist Medical Center Bolingbrook
Devices Neurology
 HSMN NewsFeed - 25 May 2017
Integrity Applications, GlucoTrack(R) Innovator, Expands Board of Directors with the Appointment of Michael Hauck
Devices Monitoring Endocrinology Personnel
 HSMN NewsFeed - 18 May 2017
EnteroMedics Announces First vBloc(R) Neurometabolic Therapy Implant at McGuire Veterans Affairs Medical Center
Devices Neurology
 HSMN NewsFeed - 23 Feb 2017
First-Ever Device for Fast and Virtually Painless Blood Draw Receives FDA Clearance
Devices FDA
 HSMN NewsFeed - 30 Jun 2016
OPKO Health to Acquire Transition Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Jan 2016
FDA Approves Animas(R) Vibe(R) Insulin Pump and Continuous Glucose Monitoring System For Use in Children
Devices Endocrinology Monitoring FDA
 HSMN NewsFeed - 5 Aug 2015
Metacrine Raises $36 Million in Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 28 Oct 2014
Hanson Medical Systems Becomes Preferred Distributor for PTS Diagnostics' CardioChek Family of Products
Diagnostics Distribution
 HSMN NewsFeed - 14 Apr 2014
Abbott Announces FDA Clearance for a New Test to Help Physicians Quickly and Accurately Diagnose Diabetes
Diagnostics Endocrinology FDA
 HSMN NewsFeed - 3 Mar 2014
U.S. FDA Approves Bydureon(R) Pen (exenatide extended-release for injectable suspension) for Once-Weekly Treatment of Adults with Type 2 Diabetes
Biopharmaceuticals Drug Delivery Endocrinology FDA
 HSMN NewsFeed - 13 Jan 2014
U.S. FDA Approves Farxiga(TM) (Dapagliflozin) Tablets for the Treatment of Adult Patients with Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 31 Dec 2013
Miraculins and Cachet Pharmaceutical Agree to 30-Day Extension on Letter of Intent to Continue Negotiation of Licensing Rights for SCOUT DS(R) Diabetes Test in China
Diagnostics Endocrinology Licensing
 HSMN NewsFeed - 26 Jul 2013
Intarcia Therapeutics Appoints Gino Santini To Its Board Of Directors
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 17 Jul 2013
Intarcia Therapeutics Appoints Dr. Eddie Li Vice President and Global Head of Regulatory Affairs
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 9 May 2013
Abbott Announces CE Mark for Test to Aid Doctors with Diagnosing and Monitoring Diabetes
Diagnostics Endocrinology Regulatory
 HSMN NewsFeed - 6 Mar 2013
GI Dynamics Announces Agreement with CMS Medical for Distribution of EndoBarrier(R) Therapy in Brazil
Devices Distribution
 HSMN NewsFeed - 8 Nov 2012
FDA Grants Diazyme Clearance to Market a New Biomarker for Early Detection of Kidney Disease, on the SMART Point of Care System
Diagnostics FDA
 HSMN NewsFeed - 10 Jul 2012
Abbott Announces New Test for the Management of Patients with Diabetes
Diagnostics Endocrinology Regulatory
 HSMN NewsFeed - 31 May 2012
New Data Showed LIVALO(R) (pitavastatin) Met Primary Endpoint of LDL-C Reduction When Compared with Pravastatin
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 22 May 2012
FDA Approves Levemir(R) for Expanded Use in Children Two to Five Years of Age with Type 1 Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 19 Apr 2012
GI Dynamics Announces First Cases of EndoBarrier(R) Therapy in Australia
Devices Gastroenterology
 HSMN NewsFeed - 25 Jan 2012
New FDA Approved Labeling For VYTORIN(R) (Ezetimibe/Simvastatin) Includes Results From the Study of Heart and Renal Protection (SHARP) in Patients With Moderate to Severe Chronic Kidney Disease
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 2 Sep 2011
EnteroMedics Announces Presentation of Maestro(R) RC System Clinical Data at the XVI World Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders
Devices Surgery
 HSMN NewsFeed - 2 Jun 2011
Animas(R) Vibe, the First Integrated Offering from Animas Corporation and Dexcom, Inc., Receives European CE Mark Approval
Devices Monitoring Drug Delivery Regulatory
 HSMN NewsFeed - 15 Nov 2010
Santarus Announces Commercial Launch of Novel Type 2 Diabetes Drug CYCLOSET
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 11 Nov 2010
FDA Approves EGRIFTA(TM) (Tesamorelin for Injection): The First and Only Treatment for the Reduction of Excess Abdominal Fat in HIV-Infected Patients With Lipodystrophy
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Oct 2010
GI Dynamics Receives European CE Mark Approval for 12 Months of EndoBarrier(TM) Treatment of Type 2 Diabetes and Obesity; Announces U.K. Launch
Devices Gastroenterology Endocrinology Regulatory
 HSMN NewsFeed - 7 Sep 2010
GI Dynamics Announces New Data Showing Significant Weight Loss, Cardiovascular and Metabolic Improvements Following 12 Months of EndoBarrier Treatment
Devices Gastroenterology
 HSMN NewsFeed - 29 Apr 2010
Ipsen's Partner Roche Announces That Taspoglutide Meets Its Primary Endpoint in a Key Phase III Clinical Trial
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 1 Dec 2009
DiaMedica Proposes to Expand Into Neurological and Other Disorders Through Acquisition of Sanomune
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 21 Oct 2009
Wellstat Therapeutics and sanofi-aventis Enter Agreement on Novel Therapy for Type II Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 9 Jun 2009
Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack
Biopharmaceuticals Endocrinology Cardiology
 HSMN NewsFeed - 24 Mar 2009
Biodel to Submit New Drug Application for VIAject to FDA
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 9 Mar 2009
DiaMedica Appoints Stephen J. Waters as Interim Chief Scientific Officer
Biopharmaceuticals Endocrinology Personnel
 HSMN NewsFeed - 17 Feb 2009
GSK Initiates Phase III Programme for Novel Type 2 Diabetes Medication, Syncria(R) (albiglutide)
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 6 Nov 2008
FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 29 Oct 2008
FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes
Biopharmaceuticals FDA Endocrinology
 HSMN NewsFeed - 26 Sep 2008
GI Dynamics Announces Promising Multi-Center Safety and Efficacy Data of EndoBarrier(TM) Gastrointestinal Liner for Pre-Surgical Weight Loss
Devices
 HSMN NewsFeed - 27 Jun 2008
ARKRAY USA Receives FDA Clearance on GLUCOCARD(TM) 01 Blood Glucose Monitoring System
Devices Monitoring Endocrinology FDA
 HSMN NewsFeed - 10 Jun 2008
Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 8 Apr 2008
DiaMedica Announces Changes to Board of Directors and Corporate Officers
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jan 2008
Medtronic Announces FDA Approval of CGMS(R) iPRO(TM) Continuous Glucose Recorder
Devices Endocrinology FDA
 HSMN NewsFeed - 7 Dec 2007
FDA Reviewing Potential Anti-Arrhythmic Claims for Ranexa(R)
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 6 Nov 2007
CV Therapeutics' Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI-36
Biopharmaceuticals Cardiology Endocrinology
 HSMN NewsFeed - 18 Oct 2007
Isis Adds New Drug to Its Development Pipeline: ISIS 388626 Targeting SGLT2 for the Treatment of Type 2 Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 21 Sep 2007
One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 28 Aug 2007
Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
Diagnostics Personnel
 HSMN NewsFeed - 21 Aug 2007
Medtronic and Bayer Diabetes Care Announce Alliance to Provide Blood Glucose Meter to Medtronic Patients Outside the United States
Devices Monitoring Endocrinology
 HSMN NewsFeed - 20 Aug 2007
Elixir Pharmaceuticals Initiates Final Phase III Clinical Study Prior to NDA
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 29 Jun 2007
Rimonabant Regulatory Update in the United States
Biopharmaceuticals
 HSMN NewsFeed - 24 Jun 2007
BYETTA(R) Study Showed Comparable Blood Glucose Control to Insulin
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 14 Jun 2007
Living Cell Technologies Announces First Diabetes Patient Successfully Dosed in Phase I/IIa DiabeCell(R) Trial
Regenerative Medicine Endocrinology
 HSMN NewsFeed - 24 Apr 2007
Journal of the American Medical Association Publishes MERLIN TIMI-36 Results
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 12 Apr 2007
XOMA Announces Clinical Trial Plans for XOMA 052 in Type 2 Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 12 Mar 2007
FDA Approves New Medtronic Continuous Glucose Monitoring Devices for Children and Teenagers
Devices FDA Endocrinology
 HSMN NewsFeed - 1 Mar 2007
Study Confirms That Significant Insulin Dose Errors Can Result When Blood Glucose Meters are Miscoded
Devices Monitoring Endocrinology
 HSMN NewsFeed - 6 Dec 2006
New Evidence Reinforces Efficacy and Tolerability of Galvus(R) as a New Once-Daily Oral Treatment Option for Patients With Type 2 Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 5 Dec 2006
New Data Shows Rimonabant Benefited Patients with Type 2 Diabetes by Improving Blood Sugar Control, Reducing Weight and Acting on Other Cardiometabolic Risk Factors
Biopharmaceuticals Endocrinology Cardiology
 HSMN NewsFeed - 4 Dec 2006
Landmark Study Shows Avandia(R) (rosiglitazone maleate) Is More Effective Than Metformin or a Sulfonylurea in Long-Term Blood Sugar Control in Type 2 Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 6 Nov 2006
Significant Errors In Insulin Dose Can Result When Blood Glucose Meters Are Miscoded According to New Clinical Study
Devices Diagnostics Monitoring Endocrinology
 HSMN NewsFeed - 11 Oct 2006
Novartis Launches 'GALIANT' Study Comparing the Investigational Drug Galvus(R) and a Leading Class of Oral Anti-Diabetic Medicines
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 10 Oct 2006
MacroGenics Receives Orphan Drug Designation From FDA for Monoclonal Antibody to Treat Type 1 Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 18 Sep 2006
Type 2 Diabetes Patients on Technosphere Insulin Exhibited No Adverse Effect on Pulmonary Function with Significant HbA1c Reductions, and Showed Significant Weight Reduction Compared to Injected Insulin Analog
Biopharmaceuticals Drug Delivery Endocrinology
 HSMN NewsFeed - 14 Sep 2006
Study Shows Exenatide Improves Blood Sugar Levels as Effectively as Biphasic Insulin Aspart
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 7 Sep 2006
Xenical(R) Shown to Improve Control of Blood Glucose Levels in People With Type 2 Diabetes Beyond Impact of Weight Loss Alone
Biopharmaceuticals
 HSMN NewsFeed - 11 Jul 2006
GlaxoSmithKline Announces FDA Approval and the Launch of Avandamet(R) (Rosiglitazone Maleate and Metformin HCl) as Initial Therapy in the Treatment of Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 6 Jul 2006
Bayer Acquires Metrika Inc.
Devices Diagnostics Mergers & Acquisitions
Return to NewsFeed  

 Additional items found! 41

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 41 additional stories matching:
HbA1c
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.